Persons over 50 or immunocompromised may experience long-term nerve damage and pain from shingles Vaccine
Shingles Vaccines Market |
When the virus that caused your chickenpox as a child
becomes active again, you develop shingles. Doctors are baffled as to why this
occurs. When the virus awakens, it causes stinging and tingling in your skin,
which can continue up to 5 days. Then blisters emerge on your body or face,
usually in a strip down one side. A fever, an upset stomach, headaches, and
chills are all possible symptoms. The rashes usually fade after a month, but
shingles can cause long-term nerve damage and pain, particularly in persons
over 50 or who are immunocompromised.
In the United States, one out of every three people will
have shingles at some point in their lives, amounting to around one million
people per year. It can strike at any age, but it becomes more common as you
become older. That's why most adults over the age of 50 should get a shingles
vaccine.
According to Coherent
Market Insights the Shingles
Vaccine Market Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018-2026.
What vaccines can
help prevent shingles?
In the United States, just one shingles vaccine is currently available. Shingrix (RZV) was
licenced in 2017 and is 90 percent effective in shingles prevention. Shingrix
requires two doses spaced between two and six months apart, with protection
lasting around 4-5 years. It is recommended by doctors for healthy adults over
the age of 50, as well as those 19 and older who are or will be immunodeficient
or immunosuppressed as a result of disease or medication.
Zostavax, a previous vaccination, was taken off the market
in 2020. That vaccination activated your immune system to combat the disease by
using a weak strain of the chickenpox virus. Shingrix, on the other hand, does
not. If you've already had the Zostavax vaccine, you should have Shingrix as
well.
Comments
Post a Comment